Osimertinib as 1st Line Therapy for Patients With Advanced EGFR Positive Non-Small Cell Lung Cancer
Clinical trial NCT05127382 · UNKNOWN
Trial details
- NCT number
- NCT05127382
- Sponsor
- Hellenic Cooperative Oncology Group
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-02-01
- Primary completion
- 2024-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.